These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16190574)

  • 21. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection.
    Vallet-Pichard A; Pol S
    J Hepatol; 2006; 44(1 Suppl):S28-34. PubMed ID: 16343684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biopsychosocial predictors of fatigue in chronic hepatitis C.
    Hilsabeck RC; Hassanein TI; Perry W
    J Psychosom Res; 2005 Feb; 58(2):173-8. PubMed ID: 15820845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients.
    Sears SF; Sowell LD; Kuhl EA; Kovacs AH; Serber ER; Handberg E; Kneipp SM; Zineh I; Conti JB
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):858-64. PubMed ID: 17584267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychiatric symptoms of hepatitis C.
    Saunders JC
    Issues Ment Health Nurs; 2008 Mar; 29(3):209-20. PubMed ID: 18340609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients.
    Cozzi A; Zignego AL; Carpendo R; Biagiotti T; Aldinucci A; Monti M; Giannini C; Rosselli M; Laffi G; Moroni F
    J Viral Hepat; 2006 Jun; 13(6):402-8. PubMed ID: 16842443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of HCV-HIV patients].
    Pol S; Cacoub P; Pialoux G; Benhamou Y; Halfon P; Rosenthal E; Perronne C
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S7-12. PubMed ID: 17965629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-induced depression in chronic hepatitis C.
    Horsmans Y
    J Antimicrob Chemother; 2006 Oct; 58(4):711-3. PubMed ID: 16951413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future directions for investigation of fatigue in chronic hepatitis C viral infection.
    Seaman K; Paterson BL; Vallis M; Hirsch G; Peltekian KM
    Chronic Illn; 2009 Jun; 5(2):115-28. PubMed ID: 19474234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Living with hepatitis C and treatment: the personal experiences of patients.
    Sgorbini M; O'Brien L; Jackson D
    J Clin Nurs; 2009 Aug; 18(16):2282-91. PubMed ID: 19583661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
    Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved cognitive function as a consequence of hepatitis C virus treatment.
    Thein HH; Maruff P; Krahn MD; Kaldor JM; Koorey DJ; Brew BJ; Dore GJ
    HIV Med; 2007 Nov; 8(8):520-8. PubMed ID: 17944685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office.
    ; Yee HS; Currie SL; Darling JM; Wright TL
    Am J Gastroenterol; 2006 Oct; 101(10):2360-78. PubMed ID: 17032203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of interferon alpha plus ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience.
    Pojoga C; Dumitraşcu DL; Pascu O; Grigorescu M
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):31-5. PubMed ID: 16680230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
    Xu DZ; Xie Y; Li ZQ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute hepatitis C: prevention and treatment.
    Ozaras R; Tahan V
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A telehealth intervention for veterans on antiviral treatment for the hepatitis C virus.
    Silberbogen AK; Ulloa E; Mori DL; Brown K
    Psychol Serv; 2012 May; 9(2):163-73. PubMed ID: 22662730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression, fatigue and neurocognitive deficits in chronic hepatitis C.
    Yeoh SW; Holmes ACN; Saling MM; Everall IP; Nicoll AJ
    Hepatol Int; 2018 Jul; 12(4):294-304. PubMed ID: 29931590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered central serotoninergic neurotransmission: a potential mechanism for profound fatigue complicating chronic hepatitis C.
    Jones EA
    Med Hypotheses; 2001 Aug; 57(2):133-4. PubMed ID: 11461159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.